Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Atrium C-Qur Hernia Mesh Lawsuits Cleared to Proceed Over Statute of Limitations Challenges August 29, 2019 Irvin Jackson Add Your Comments A federal judge has cleared the way for two product liability lawsuit over problems with Atrium C-Qur hernia mesh to proceed, rejecting efforts by the manufacture to have the cases dismissed. Atrium currently faces about 1,500 hernia mesh lawsuits pending throughout the federal court system, each involving similar allegations C-Qur (pronounced “secure”) surgical repair products were defectively designed and unreasonably dangerous, increasing the risk of complications and infection, often resulting in the need for additional surgery to remove or replace the mesh. The Atrium C-Qur mesh was introduced in March 2006, and was widely used by surgeons throughout the U.S. for several years, featuring a unique design involving polypropylene mesh with an Omega-3 fatty acid (O3FA) gel coating. While this was designed to reduce scar tissue formation and promote fixation of the mesh to the abdominal wall, the C-Qur patch has been linked to a large number of reported problems, including inflammatory responses, bowel adhesions and other painful complications. Hernia Mesh Lawsuits Did you or a loved one receive a hernia mesh? Hernia mesh lawsuits are being filed against Bard, Atrium, Covidien and several other hernia mesh manufacturers over mesh failures resulting in injuries and additional surgery. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Hernia Mesh Lawsuits Did you or a loved one receive a hernia mesh? Hernia mesh lawsuits are being filed against Bard, Atrium, Covidien and several other hernia mesh manufacturers over mesh failures resulting in injuries and additional surgery. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Given similar questions of fact and law raised in the complaints, the U.S. Judicial Panel on Multidistrict Litigation (JPML) established consolidated pretrial proceedings for all Atrium C-Qur hernia mesh cases in December 2016, centralizing complaints filed in U.S. District Courts nationwide in New Hampshire, where U.S. District Judge Landya McCafferty is coordinating discovery, pretrial rulings and overseeing a “bellwether” process for a group of representative claims that will be the first to go before juries. In court orders issued earlier this month, Judge McCafferty denied motions to dismiss filed in bellwether claims brought by Felicia Blackwood (PDF) and Joseph Shumaker (PDF), rejecting arguments made by Atrium that the claims were time-barred under the three year statute of limitations in New Hampshire. Statute of limitations laws, which vary by state, require that legal actions be filed within a certain amount of time between when an individual knew or reasonably could have discovered that a product caused an injury. In both cases, Atrium claimed that the plaintiffs waited too long between discovering their injuries and filing a lawsuit. However, Judge McCafferty disagreed in both cases, indicating that it is reasonable to assume the plaintiffs did not learn design problems with the hernia mesh were the cause of their injuries until much later. In Blackwood’s case, she went to the hospital with abdominal pain in February 2013, which Atrium argued resulted in a statute of limitations deadline that required her case be filed by February 2016. However, Blackwood maintains that she did not discover the cause of her pain until September 2013, during a procedure where the hernia patch was surgically removed. Judge McCafferty determined that her statute of limitations would not expire until August 2016, making the filing of her lawsuit timely. In Shumaker’s case, the plaintiff argued that although the mesh was removed more than three years before his lawsuit was filed, additional time should be allowed under the statute of limitations, since Atrium concealed problems with mesh design and mislead physicians, preventing him and his doctors from discovering that problems with the mesh caused the failure. “Taking Shumaker’s allegations in the light most favorable to him and resolving reasonable inferences in his favor, Shumaker’s allegations are sufficient to preclude dismissal of his product liability claims as time-barred at this stage of the litigation,” Judge McCafferty wrote. “If, as the case develops through discovery, defendants find facts that support the statute-of-limitations defense, they may raise that defense at an appropriate time, such as in a motion for summary judgment.” Earlier this year, Judge McCafferty began allowing direct filing of claims to the Atrium C-Qur MDL, and began the process of preparing a small group of cases for early bellwether trials. While the outcomes of these “bellwether” trials will not be binding on other claims, the process is designed to facilitate potential hernia mesh settlements that may be necessary to avoid the need for hundreds of individual trials in various U.S. District Courts nationwide following the coordinated MDL proceedings. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Atrium C-Qur, Atrium Medical, Hernia, Hernia Mesh, Statute of Limitations More Hernia Mesh Lawsuit Stories Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications September 8, 2025 Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 August 21, 2025 LifeCell Seeks Dismissal of Strattice Hernia Mesh Lawsuit Set for Trial August 11, 2025 0 Comments FacebookThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Mother’s Lawsuit Indicates 5-Year-Old Girl Sexually Exploited on Roblox (Posted: yesterday) A new lawsuit against Roblox alleges that the platform’s inadequate safety measures enabled multiple sexual predators to exploit a five-year-old girl. MORE ABOUT: ROBLOX LAWSUITRoblox Sextortion Lawsuit Alleges Teen Committed Suicide After Being Groomed, Blackmailed (10/02/2025)MDL Sought for Roblox Lawsuits Over Child Sexual Exploitation and Assault Epidemic (09/23/2025)Safety Problems With Roblox and Discord Endangered Young Girl: Lawsuit (09/16/2025) Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (Posted: 2 days ago) Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm. MORE ABOUT: BREAST MESH LAWSUITFDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023) Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: 3 days ago) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)
Mother’s Lawsuit Indicates 5-Year-Old Girl Sexually Exploited on Roblox (Posted: yesterday) A new lawsuit against Roblox alleges that the platform’s inadequate safety measures enabled multiple sexual predators to exploit a five-year-old girl. MORE ABOUT: ROBLOX LAWSUITRoblox Sextortion Lawsuit Alleges Teen Committed Suicide After Being Groomed, Blackmailed (10/02/2025)MDL Sought for Roblox Lawsuits Over Child Sexual Exploitation and Assault Epidemic (09/23/2025)Safety Problems With Roblox and Discord Endangered Young Girl: Lawsuit (09/16/2025)
Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications (Posted: 2 days ago) Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm. MORE ABOUT: BREAST MESH LAWSUITFDA Warns BD Surgical Mesh Products Not Proven Safe for Breast Reconstruction Surgery (11/10/2023)
Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (Posted: 3 days ago) Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety. MORE ABOUT: DUPIXENT LAWSUITDupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)Dupixent Cutaneous T-Cell Lymphoma Warning Label Update Being Evaluated by FDA (09/15/2025)Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (09/04/2025)